XNCR — Xencor Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Xencor Inc

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$11.63
Market Cap$836M
Float54.5M
Shares Outstanding74.1M
P/E (Forward)68.03
Price/Sales (TTM)8.62
vs. Analyst Target+145.1% to analyst PT
Profit Margin-177.10%
Operating Margin (TTM)-1724.14%
Revenue (TTM)$97.4M
Dividend RateNone
Analyst Target Price$28.50 (12 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $123M -$63.5M $123M -$71.0M
2021 $275M $82.6M $275M $51.3M
2022 $165M -$55.2M $165M -$73.7M
2023 $168M -$126M -$85.3M -$126M
2024 $110M -$233M $110M -$186M
2025 $126M -$91.9M $115M -$47.0M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $43.6M -$30.8M
Sep 2025 $21.0M -$6.0M
Dec 2025 $28.2M -$6.7M
Mar 2026 $4.5M -$129M

Ownership & Float

Insider Ownership1.2%
Institutional Ownership115.4%
Short Float19.3%
% of All Funds Holding2.28%
Number of Funds Holding187

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$12.24Near-term / short-term trend
Weekly40-Week SMA$12.82Medium-term trend
Weekly80-Week SMA$13.27Cyclical trend (business cycle)
Weekly200-Week SMA$19.66Secular trend (multi-year)
Monthly10-Month SMA$12.77Near-term monthly trend
Monthly20-Month SMA$13.84Medium-term monthly trend
Monthly40-Month SMA$18.10Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$8.20 support 1.50x 7 months ago
$26.70 resistance 1.33x 16 months ago

Historical Earnings Reactions (50 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.68% 0.21% 54.00% 15.42% -9.44%
1 Day -0.39% -0.43% 46.00% 10.31% -20.03%
1 Week -0.85% -1.12% 44.00% 12.24% -17.31%
2 Weeks 0.00% -0.30% 48.00% 30.57% -21.04%
1 Month 1.72% 0.36% 51.02% 38.91% -24.83%

Next earnings: July 25, 2026 (59 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-6.1%23.1%13
Feb4.6%61.5%13
Mar-5.2%23.1%13
Apr-3.6%15.4%13
May1.8%58.3%12
Jun8.8%58.3%12
Jul0.1%58.3%12
Aug-1.6%41.7%12
Sep1.7%41.7%12
Oct0.6%50.0%12
Nov14.9%91.7%12
Dec0.6%50.0%12

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.05% 47.9% 587
Tuesday 0.01% 48.5% 646
Wednesday 0.31% 51.1% 642
Thursday -0.22% 44.5% 631
Friday 0.18% 50.7% 629

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 115.4%

Insider Transactions — Smart Summary

Total insider ownership: 1.2%

Founder-led management: Bassil Dahiyat (Chief Executive Officer, President & Director)

12-Month Insider Activity Summary

Total Filings15
Net Value-$960,612.858
Net Shares Change161,840
% of Float0.3%
C-Suite Filings10
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Dahiyat Bassil I PRESIDENT and CEO -$553,503.022 3 3 sell
Desjarlais John R SR. VICE PRESIDENT and CSO -$262,114.635 3 3 sell
Eckert Celia SVP, GENERAL COUNSEL -$73,699.814 2 2 sell
Cornelissen Bart Jan SR. VICE PRESIDENT and CFO -$71,295.387 2 2 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-06-16 – 2025-06-16 5 5 -$132,463.74
2026-03-04 – 2026-03-09 7 4 -$527,964.775 7 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-04 Eckert Celia SVP, GENERAL COUNSEL -$17,747.489 Transaction at $11.90, now -2.2%
2026-03-04 Dahiyat Bassil I PRESIDENT and CEO -$80,387.086 Transaction at $11.90, now -2.2%
2026-03-09 Eckert Celia SVP, GENERAL COUNSEL -$55,952.325 Transaction at $11.17, now +4.2%
2026-03-04 Desjarlais John R SR. VICE PRESIDENT and CSO -$31,676.651 Transaction at $11.90, now -2.2%
2026-04-13 Cornelissen Bart Jan SR. VICE PRESIDENT and CFO -$42,990.464 Transaction at $12.29, now -5.3%
2026-03-09 Desjarlais John R SR. VICE PRESIDENT and CSO -$73,880.524 Transaction at $11.16, now +4.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Xencor Inc (XNCR) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for XNCR on Trend Edge →